JHS Svendgaard Laboratories Ltd
Fundamental Score
JHS Svendgaard Laboratories Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of JHS across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (98.06%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Below-Average Return on Equity (-10.84%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-5.19%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-2.96%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Limited Growth History (-7.94% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Interest Coverage (-9.23x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-36.74 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 1.57%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for JHS Svendgaard Laboratories Ltd
About JHS
Business Overview
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
Company Details
Key Leadership
Corporate Events
JHS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of JHS Svendgaard Laboratories Ltd (JHS)?
As of 10 Feb 2026, 12:00 pm IST, JHS Svendgaard Laboratories Ltd (JHS) is currently trading at ₹10.79. The stock has a market capitalization of ₹94.41 (Cr).
Is JHS share price Overvalued or Undervalued?
JHS is currently trading at a P/E ratio of 0.00x, compared to the industry average of 50.39x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the JHS Svendgaard Laboratories Ltd share price?
Key factors influencing JHS's price include its quarterly earnings growth (Sales Growth: 13.21%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is JHS Svendgaard Laboratories Ltd a good stock for long-term investment?
JHS Svendgaard Laboratories Ltd shows a 5-year Profit Growth of N/A% and an ROE of -10.84%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.06 before investing.
How does JHS Svendgaard Laboratories Ltd compare with its industry peers?
JHS Svendgaard Laboratories Ltd competes with major peers in the Personal Care. Investors should compare JHS's P/E of 0.00x and ROE of -10.84% against the industry averages to determine its competitive standing.
What is the P/E ratio of JHS and what does it mean?
JHS has a P/E ratio of N/Ax compared to the industry average of 50.39x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is JHS performing according to Bull Run's analysis?
JHS has a Bull Run fundamental score of 13.3/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does JHS belong to?
JHS operates in the Personal Care industry. This classification helps understand the competitive landscape and sector-specific trends affecting JHS Svendgaard Laboratories Ltd.
What is Return on Equity (ROE) and why is it important for JHS?
JHS has an ROE of -10.84%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently JHS Svendgaard Laboratories Ltd generates profits from shareholders' equity.
How is JHS's debt-to-equity ratio and what does it indicate?
JHS has a debt-to-equity ratio of 0.06, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is JHS's dividend yield and is it a good dividend stock?
JHS offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has JHS grown over the past 5 years?
JHS has achieved 5-year growth rates of: Sales Growth -7.94%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in JHS and why does it matter?
Promoters hold 34.56% of JHS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is JHS's market capitalization category?
JHS has a market capitalization of ₹94 crores, placing it in the Small-cap category.
How volatile is JHS stock?
JHS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for JHS?
JHS has a 52-week high of ₹N/A and low of ₹N/A.
What is JHS's operating profit margin trend?
JHS has a 5-year average Operating Profit Margin (OPM) of -2.96%, indicating the company's operational efficiency.
How is JHS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 13.21% and YoY Profit Growth of 98.06%.
What is the institutional holding pattern in JHS?
JHS has FII holding of 1.57% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.